Business Operation · 2025
In this section22 topics
- Corporate Information4 items
- Dividend Policy2 items
- Major Shareholders1 item
- Business Strategies Overview5 items
- Material Changes & Developments1 item
- Use of Proceeds from Securities Offerings1 item
- Commitments Made in the Registration Statement1 item
- Group Operating-Structure Policy1 item
- Companies Where the Company Holds ≥10%1 item
- Shareholders with Potential Conflict of Interest1 item
- Relationships Among Major Shareholders1 item
- Shareholders' Agreement1 item
- Shareholding Diagram (Group Structure)2 items
- Income Structure3 items
- Product / Service Characteristics2 items
- Research & Development2 items
- Assets Used in the Business4 items
- Marketing Policy & Competition3 items
- Procurement of Products & Services2 items
- Projects Under Construction1 item
- Debentures & Bills of Exchange1 item
- Convertible Securities2 items
Corporate Information
Company Name
E FOR L AIM PUBLIC COMPANY LIMITED
Telephone
0-2883-0871-9
Website
www.eforl-aim.com
IR@eforl-aim.com
Dividend Policy
Dividend Policy
The Company has a policy to distribute dividends at a rate of not less than 40 percent of net profits of the separate financial statements after corporate income tax and legal reserves, and other accumulated funds as determined by the company. However, the dividend payment may be subject to change depending on the financial status, operational results, investment plans, and other future considerations, as deemed appropriate by the Company's board of directors and/or shareholders.
Historical Dividend Payments
| This Year | Last Year | 2 Years Ago | 3 Years Ago | 4 Years Ago | Metric | Description |
|---|---|---|---|---|---|---|
| 0.01 | 0 | 0 | 0.01 | 0.02 | Net profit per share (Baht : Share) | Net profit per share (baht : share) |
| 0 | 0 | 0 | 0 | 0 | Dividend per share (Baht : Share) | Dividend per share (baht : share) |
| 0 | 0 | 0 | 0 | 0 | Dividend stock ratio (Number of original shares: dividend shares) | Ratio of stock dividend payment (existing share : stock dividend) |
| 0 | 0 | 0 | 0 | 0 | Dividend share value per share (Baht : Share) | Value of stock dividend per share (baht : share) |
| 0 | 0 | 0 | 0 | 0 | Total dividend payment value (Baht : Share) | Total dividend payment (baht : share) |
| 0 | 0 | 0 | 0 | 0 | Dividend payout ratio to net profit (%) | Dividend payout ratio compared to net profit (%) |
Business Strategies Overview
Vision
To be a leading distributor of high-quality medical equipment and devices with advanced innovations, delivering reliable service and ensuring customer satisfaction for the improved well-being of the people.
Objectives
To deliver high-quality products and services that meet international standards through advanced technology.
Goals
To be a leader in the distribution of medical devices and medical supplies, with emphasis on quality and advanced technology, and to maintain credibility at the international level.
To expand into other businesses within the medical device sector in order to create growth opportunities and increase revenue.
To remain committed to delivering services that enhance customer satisfaction and confidence in product quality, supported by effective after-sales services.
To improve operational processes and logistics systems to enhance efficiency and reduce overall costs.
To maintain strong relationships with customers and manufacturers in order to create opportunities for business and market expansion.
Business Strategies
Training and Personnel Development: Promote continuous learning of new technologies and provide ongoing training on advanced medical devices to enhance service capabilities and effectively respond to customer needs.
After-Sales Service: Provide close support and follow-up on product usage, with comprehensive after-sales services available, including inspection and troubleshooting 24 hours a day.
Customer Satisfaction Enhancement: Establish regular customer visits to assess satisfaction levels and utilize feedback to continuously improve and refine service delivery.
Other Information
| Name | Description |
|---|---|
| Marketing Strategies |
|
| Business Expansion Strategies |
|
Material Changes & Developments
Material Changes & Developments
| Year | Description |
|---|---|
| 2,023 |
|
Use of Proceeds from Securities Offerings
Is There Money Raised from a Securities Offering Still to Report On?
No
Commitments Made in the Registration Statement
Are There Commitments or Conditions from an Offering or Listing?
No
Group Operating-Structure Policy
Description
E For L Aim Public Company Limited (Parent company)
Operates primarily as an importer and distributor of medical devices and equipment. Additionally, the Company provides services for maintenance, repair, and comprehensive knowledge on the use of medical instruments and equipment.
Spacemed Company Limited (Subsidiary company)
The Company holds 100.00 percent of the shares with a registered capital of THB 50.00 million. Business nature: Distributor of medical devices and equipment.
Companies Where the Company Holds ≥10%
Companies (≥10% Holding)
| Company Name | Address | Province | Zip Code | Telephone | Business Type | Security Type | Shares | Paid-up Shares |
|---|---|---|---|---|---|---|---|---|
| Spacemed Co., Ltd. | No. 160, Ngamwongwan Road, Bangkhen, Mueang Nonthaburi | Nonthaburi | 11000 | 02-114-3023 | A distributor of medical devices and equipment | Common shares | 500,000 | 500,000 |
Income Structure
Product / Service Income
| Category | Description | This Year | This Year % | Last Year | Last Year % | 2 Years Ago | 2 Years Ago % |
|---|---|---|---|---|---|---|---|
| Total revenue from operations | Total revenue from operations | 1,314,694 | 100 | 1,354,598 | 100 | 1,317,669 | 100 |
| Revenues from sales of medical equipment and services | 1,305,568 | 99.31 | 1,340,007 | 98.92 | 1,309,839 | 99.41 | |
| Other | Others | 9,126 | 0.69 | 14,591 | 1.08 | 7,830 | 0.59 |
Export Income
| Category | Description | This Year | This Year % | Last Year | Last Year % | 2 Years Ago | 2 Years Ago % |
|---|---|---|---|---|---|---|---|
| Total revenue | Total revenue | 1,314,694 | 100 | 1,354,598 | 100 | 1,317,669 | 100 |
| Domestic | Domestic | 1,314,694 | 100 | 1,354,598 | 100 | 1,317,669 | 100 |
| International | International | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income
| Operating Other Income | Non-Operating Other Income | Share of Profit |
|---|---|---|
| 1710 · As of year: 9126.0 · Description: Total other income · As of yesteryear: 14591.0 · As of year before yesteryear: 7830.0 · 1711 · As of year: 9126.0 · Description: Other income from operations · As of yesteryear: 14591.0 · As of year before yesteryear: 7830.0 | 1712 · As of year: 0.0 · Description: Other income not from operations · As of yesteryear: 0.0 · As of year before yesteryear: 0.0 | 1713 · Description: Share of profit |
Product / Service Characteristics
Business Type
3115
Business Groups
| Business Group | Description |
|---|---|
| Medical devices and equipment |
|
| Diagnostic products and laboratory reagents |
|
| Product of Spacemed Co., Ltd. (Subsidiary company) | Engages in the business of selling medical equipment and research instruments and has been appointed as an authorized distributor for products including microscopes, automatic arm-in blood pressure monitors, weighing scales, Nitric Oxide delivery system, enteral feeding pump, and more. |
Research & Development
Has R&D Policy (Y/N)
No
R&D Cost — Label
Research and development (R&D) expenses over the past 3 years (Million Baht)
Assets Used in the Business
Permanent Assets — Description
Fixed assets of the Company and its subsidiaries consist of land, buildings and improvements, medical tool and equipment, tool and equipment, fixtures and office equipment, and vehicles. Details are in the attachment 4: Assets for Business Operation and Details about the Property Appraiser.
Intangible Assets — Description
The intangible assets of the Company and its subsidiaries consist of computer software. Details are in the attachment 4: Assets for Business Operation and Details about the Property Appraiser.
Has Subsidiaries Investment Policy (Y/N)
Yes
Subsidiaries Investment Policy — Description
The Company has a policy to focus on investments in businesses that are related to and support its core business of distributing medical equipment and devices. The objective is to enhance competitiveness and expand long-term business opportunities. The Company places importance on investing in enterprises that can generate synergies with its existing operations, particularly in terms of product portfolio, distribution networks, and customer base.
Currently, the Company invests through its subsidiary, Spacemed Co., Ltd., which engages in the distribution of medical equipment and devices for professional use in healthcare institutions (Professional Use), medical equipment and devices for home use (Home Use), as well as scientific instruments (Microscopes). The Company holds a 100% equity interest in the subsidiary.
Such investment expands the Company’s product scope from institutional customers to individual consumers and home healthcare segments, in line with Thailand’s aging society trend and the continued growth of the domestic healthcare market.
Marketing Policy & Competition
Reporting Mode
3117
Marketing Policy (Overall)
Products and Services
The Company has carefully selected leading medical equipment and devices products that are widely recognized in the medical and healthcare industry. The Company has been appointed as the exclusive distributor for several key products, such as Hamilton Medical (Switzerland), Nihon Kohden (Japan), and GE Healthcare (USA), among others. The Company emphasizes product quality and excellent pre-sales and after-sales services. It strives to reach its primary customer groups through regular visits, offering advice, and providing solution-oriented proposals. In addition to regular visits, the Company offers a service plan called the Golden Service Program, providing full support as follows:
24-hour On-Call Service: Customers may seek consultation and technical assistance regarding product usage at any time.
Timely Service Response: After receiving a service request, on-site service is provided within 48 hours in the Bangkok Metropolitan Area and surrounding provinces, and within 72 hours in other provinces.
Backup Support Plan: In cases where repairs cannot be completed within the specified timeframe, the Company implements a backup plan to minimize operational disruptions for customers.
The Company is committed to driving innovation and expanding business opportunities through various strategic initiatives, including:
Supporting the development of hospital infrastructure, from general hospital systems to specialized medical centers.
Participating in the advancement of Telemedicine and Electronic Medical Records (EMR) to enhance healthcare accessibility and efficiency.
Expanding market reach through Turnkey Projects and innovative product initiatives, such as ozone gas sterilization systems and dental unit chairs.
Focusing on software solutions that integrate with medical devices, including both proprietary developments and imported software, while further advancing AI-driven healthcare solutions to enhance diagnostic and treatment capabilities, an area with significant growth potential.
Marketing Promotion
Sales promotion and advertising of the products distributed by the Company are key marketing strategies that the Company prioritizes. The Company continuously engages in marketing activities to raise awareness and provide information about its products to medical professionals through various channels, such as participating in academic conferences, product exhibitions, and presentations.
In 2025, the Company participated in a medical device exhibition organized by the Urological Association of Thailand under Royal Patronage to strengthen relationships and expand its customer base among medical specialists.
Pricing
The Company primarily determines its prices through government auctions, which are competitive pricing methods. The prices generally set by the government for each product category serve as guidelines for determining selling prices for individual customers. However, for products that do not have government-set prices, the prices will be determined by considering product quality, import costs, and standard profits to remain competitive and fair to its customers.
Distribution channel
For government customers, the primary sales channels are government auctions and procurement projects, especially for special projects and urgent requirements, whereas customers in the private sector have access to direct sales channels through the Company's representatives and distributors.
In the future, the Company plans to emphasize sales channels related to Customer Relationship Management (CRM) systems through its websites and various blogs, particularly for specific products.
Industry & Competition (Overall)
The medical device industry in Thailand experienced intensified competition over the past year, particularly among distributors of medical equipment and devices. The industry has been influenced by several key factors as follows:
Market Growth and Increasing Demand
Thailand’s transition into an aging society, together with the expansion of private hospital services, has led to continued growth in demand for medical devices.
Healthcare institutions have increasingly invested in advanced medical technologies, including AI applications and digital health systems.
Essential equipment for treatment and diagnosis, such as ventilators and diagnostic devices, has experienced sustained growth in demand.
Competition from Major and New Players
Multinational corporations such as GE Healthcare, Siemens Healthineers, and Philips hold significant market share.
New market entrants, particularly from China and South Korea, offer products at more competitive price levels, resulting in significant pricing pressure.
Domestic distributors are required to expand their product portfolios and enhance value-added services to maintain competitiveness.
Price and Cost Pressures
The appreciation of the Thai Baht during certain periods has affected the import costs of medical equipment.
Public hospitals face budget constraints, leading to careful consideration of cost-effective procurement options.
Intensifying price competition has required companies to strengthen after-sales services to create additional value for customers.
Adaptation Strategies for Distributors
Distributors have focused on forming strategic partnerships and expanding after-sales services, such as maintenance and technical consultation.
The adoption of AI and IoT technologies has been implemented to enhance equipment efficiency and strengthen competitive positioning.
Sales and service teams have been expanded to cover Bangkok, its surrounding areas, and other provinces nationwide.
Impact of Online Competitors
The COVID-19 pandemic led to the emergence of more online competitors, particularly in lower-technology products that do not require after-sales services.
However, the medical device market continues to require professional expertise in consultation and after-sales support. As a result, the impact of such online competitors on traditional distributors remains limited.
Overall, the medical device industry in Thailand faces heightened competition from both existing and new market players. While demand for medical equipment continues to grow, driven by healthcare and technological factors, distributors are increasingly challenged by cost and pricing pressures. The ability to adapt through enhanced after-sales services, strategic partnerships, and the application of technology will be critical in sustaining competitiveness and achieving long-term business sustainability.
Procurement of Products & Services
Reporting Mode
3117
Procurement (Overall)
The medical equipment and devices distributed by the Company are officially appointed from overseas manufacturers. The products are primarily imported from various countries, including Europe, the United States, and Japan, under formal distribution agreements with each respective manufacturer.
Projects Under Construction
Has Projects Under Construction (Y/N)
No
Debentures & Bills of Exchange
Has Debentures (Y/N)
No
Convertible Securities
Has Convertible Securities (Y/N)
Yes
Convertible Securities
| Security Name | Issued Date | Exercise Date(s) | Maturity Date | Exercise Price | Exercise Ratio | Allotted Shares | Convertible Shares | Unconverted Shares | Remaining Convertible | Notification Period | Description |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants to purchase ordinary shares of E for L Aim Public Company Limited Series 6 (EFORL-W6) | 2022-05-31 | - 30 November 2022 - 31 May 2023 - 30 November 2023 - 31 May 2024 - 30 November 2024 - 31 May 2025 | 2025-05-31 | 2.5 | 1.000:1.000 | 75,614,910 | 75,614,910 | 0 | 75,411,730 | Within 5 business days before the Exercise Date except from Final Excercise of Rights Notification period: 15 days before the final exercise date | The Company’s Warrants No.6 (EFORL-W6) expired to be listed securities. |

